In April 2012, PLOS Medicine published an article by three researchers who were involved in ongoing updates of a Cochrane Collaboration review of neuraminidase inhibitors for treating influenza, describing their experience of trying to gain access to clinical study reports for the antiviral Tamiflu (oseltamivir) from the drug's manufacturer Roche.
Donald Rumsfeld, formerly United States Secretary of Defense, is a past board member and current minor shareholder of Gilead Sciences which owns intellectual property rights to Oseltamivir (also called "Tamiflu").